Cite
Efficacy and Safety of Methotrexate for the Treatment of Autoimmune Virus-Negative Myocarditis: A Case Series.
MLA
Campochiaro, Corrado, et al. “Efficacy and Safety of Methotrexate for the Treatment of Autoimmune Virus-Negative Myocarditis: A Case Series.” Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases, vol. 27, no. 4, June 2021, pp. e143–46. EBSCOhost, https://doi.org/10.1097/RHU.0000000000000897.
APA
Campochiaro, C., De Luca, G., Sartorelli, S., Tomelleri, A., Esposito, A., Candela, C., Cavalli, G., & Dagna, L. (2021). Efficacy and Safety of Methotrexate for the Treatment of Autoimmune Virus-Negative Myocarditis: A Case Series. Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases, 27(4), e143–e146. https://doi.org/10.1097/RHU.0000000000000897
Chicago
Campochiaro, Corrado, Giacomo De Luca, Silvia Sartorelli, Alessandro Tomelleri, Antonio Esposito, Caterina Candela, Giulio Cavalli, and Lorenzo Dagna. 2021. “Efficacy and Safety of Methotrexate for the Treatment of Autoimmune Virus-Negative Myocarditis: A Case Series.” Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases 27 (4): e143–46. doi:10.1097/RHU.0000000000000897.